Cardiovascular safety of etoricoxib
Meticulous attention is paid to the cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs), the so-called selective cyclooxy-genase 2 (COX-2) inhibitors in particular. The author considers precisely this matter in case of Russia's recent NSAID etoricoxib that has been tested alo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/371 |